Back to Results
First PageMeta Content
Drug discovery / Protein kinase inhibitors / Cancer research


Reprint from January 8, 2007 BioCentury THE BERNSTEIN REPORT ARTICLE REPRINT
Add to Reading List

Document Date: 2008-03-07 11:41:51

Open Document

File Size: 64,06 KB

Share Result on Facebook

City

South San Francisco / San Francisco / New York / Tokyo / Indianapolis / London / Basel / /

Company

Merck & Co. Inc. / Eli Lilly and Co. / Array BioPharma Inc. / Bristol-Myers Squibb Co. / BIOCENTURY PUBLICATIONS INC. / Novartis AG / Cytokinetics Inc. / Kyowa Hakko Kogyo Ltd. / GlaxoSmithKline plc / D. / CYTK / /

Country

Switzerland / Japan / United Kingdom / /

Event

FDA Phase / Business Partnership / /

Facility

Whitehouse Station / /

/

IndustryTerm

chemical composition / /

MedicalCondition

latestage cancer / solid tumors / peripheral neuropathy / solid cancers / breast cancer / platinum-sensitive lung cancer / cancers / tumor / cancer / tumors / hematologic cancers / /

Person

Disrupting / KAREN BERNSTEIN / Kevin Koch / Robert Blum / Aaron Bouchie / /

/

Position

president / molecular DAVID FLORES President / CEO / Writer / Chairman & Editor-in-Chief / Ph. Chairman & Editor-in-Chief / /

Product

MK-0731 / Eg5 / SB743921 / ARRY-520 / /

ProvinceOrState

New Jersey / Indiana / New York / California / Colorado / /

Technology

apoptosis / pharmacokinetics / /

URL

www.biocentury.com / /

SocialTag